Celularity Inc. (NASDAQ:CELUW) Short Interest Up 628.4% in May

Celularity Inc. (NASDAQ:CELUW) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 24,342 shares, an increase of 628.4% from the April 30th total of 3,342 shares. Based on an average daily trading volume, of 16,940 shares, the days-to-cover ratio is currently 1.4 days.

Celularity Price Performance

NASDAQ CELUW opened at $0.01 on Thursday. Celularity has a fifty-two week low of $0.01 and a fifty-two week high of $0.08. The business has a fifty day moving average of $0.01 and a 200-day moving average of $0.01.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.